{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:04:46Z","timestamp":1781715886946,"version":"3.54.5"},"reference-count":54,"publisher":"American Diabetes Association","issue":"4","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"DOI":"10.13039\/100008713","name":"Diabetes Australia Research Trust","doi-asserted-by":"publisher","award":["Y24G-KANP"],"award-info":[{"award-number":["Y24G-KANP"]}],"id":[{"id":"10.13039\/100008713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1183737"],"award-info":[{"award-number":["1183737"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","award":["1-SRA-2022-1204-S-B"],"award-info":[{"award-number":["1-SRA-2022-1204-S-B"]}],"id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Chronic low-grade inflammation underlies many microvascular complications of diabetes, including diabetic kidney disease (DKD). Lipoxins (LXs), an endogenously produced family of lipid mediators, resolve inflammation and protect against renal scarring as occurs in DKD. This study examined the mechanism by which LXs protect against DKD, focusing on the regulation of VCAM-1 and the recruitment of macrophages to the diabetic glomerulus. LXA4 and two fourth-generation mimetics were assessed in diabetic ApoE knockout mice, followed by in\u00a0vitro studies in the main renal cell populations, including podocytes, proximal tubular, mesangial, and glomerular endothelial cells. LXs attenuated albuminuria, mesangial expansion, and collagen and fibronectin deposition as both a preventive and delayed intervention in experimental DKD. LXs also consistently attenuated the TNF-\u03b1\u2013induced expression\u00a0of VCAM-1 in all the human and mouse renal cell populations examined. Further analysis identified that the renoprotection was in part mediated by an epigenetic modification of the VCAM-1 gene through H3K4 monomethylation, which did not appear to be dependent on NF-\u03baB activation in human glomerular endothelial cells. LXs protect against DKD by modulating glomerular endothelial cell inflammation and via a novel LX-mediated epigenetic mechanism regulating the VCAM-1 promoter in these cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Article Highlights<\/jats:title>\n                    <jats:p>Lipoxins (LXs) protect against diabetic kidney disease (DKD) by resolving chronic low-grade inflammation, but the exact mechanism by which this occurs is not known. We investigated the effect of LXs on inflammatory markers and the recruitment of macrophages to the diabetic glomerulus by using LXs as both a preventive and delayed interventional treatment in streptozotocin-induced diabetic ApoE knockout mice. Protection against DKD was associated with reduced glomerular macrophage accumulation. LXs also attenuated the expression of VCAM1 in glomerular endothelial cells. LXs protect against DKD in part by a mechanism that reduces VCAM1 gene expression via H3K4 monomethylation on the VCAM1 gene.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/db25-0970","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T15:50:43Z","timestamp":1771429843000},"page":"710-725","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic Regulation of VCAM-1 by Lipoxin A4 Is Renoprotective Against Diabetic Kidney Disease"],"prefix":"10.2337","volume":"75","author":[{"given":"Madhura","family":"Bose","sequence":"first","affiliation":[{"name":"Department of Diabetes, Monash University 1 , Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthukumar","family":"Mohan","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Monash University 1 , Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Okabe","sequence":"additional","affiliation":[{"name":"Epigenetics in Human Health and Disease Program, Baker Heart and Diabetes Institute 2 , Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harikrishnan","family":"Kaipananickal","sequence":"additional","affiliation":[{"name":"Epigenetics in Human Health and Disease Program, Baker Heart and Diabetes Institute 2 , Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Priori","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Monash University 1 , Melbourne, Australia"},{"name":"INSERM, UMR-S1149, Centre de Recherche sur l\u2019Inflammation (CRI), Universit\u00e9 Paris-Cit\u00e9 3 , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Chhor","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Monash University 1 , Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karly C.","family":"Sourris","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Monash University 1 , Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramtin","family":"Radman","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Monash University 1 , Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Tikellis","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Monash University 1 , Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Monash University 1 , Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assam","family":"El-Osta","sequence":"additional","affiliation":[{"name":"Epigenetics in Human Health and Disease Program, Baker Heart and Diabetes Institute 2 , Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4908-5474","authenticated-orcid":false,"given":"Eoin","family":"Brennan","sequence":"additional","affiliation":[{"name":"Diabetes Complications Research Centre, Conway Institute and School of Medicine, University College Dublin 4 , Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Guiry","sequence":"additional","affiliation":[{"name":"UCD School of Chemistry, University College Dublin 5 , Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Gahan","sequence":"additional","affiliation":[{"name":"UCD School of Chemistry, University College Dublin 5 , Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Tighe","sequence":"additional","affiliation":[{"name":"UCD School of Chemistry, University College Dublin 5 , Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merlin","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Monash University 1 , Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Jandeleit-Dahm","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Monash University 1 , Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Godson","sequence":"additional","affiliation":[{"name":"Diabetes Complications Research Centre, Conway Institute and School of Medicine, University College Dublin 4 , Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6260-1643","authenticated-orcid":false,"given":"Phillip","family":"Kantharidis","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Monash University 1 , Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Monash University 1 , Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"2026061712274771200_B1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(98)01346-4","article-title":"Pathogenesis, prevention, and treatment of diabetic nephropathy","volume":"352","author":"Cooper","year":"1998","journal-title":"Lancet"},{"key":"2026061712274771200_B2","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/sj.ki.5000377","article-title":"Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective","volume":"69","author":"Parving","year":"2006","journal-title":"Kidney Int"},{"key":"2026061712274771200_B3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrneph.2015.173","article-title":"Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease","volume":"12","author":"Thomas","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"2026061712274771200_B4","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"2026061712274771200_B5","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"2026061712274771200_B6","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1001\/jama.287.19.2563","article-title":"Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus","volume":"287","author":"Writing Team for the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group","year":"2002","journal-title":"JAMA"},{"key":"2026061712274771200_B7","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.2019.3471","article-title":"Resurgence in diabetes-related complications","volume":"321","author":"Gregg","year":"2019","journal-title":"JAMA"},{"key":"2026061712274771200_B8","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990-2010","volume":"370","author":"Gregg","year":"2014","journal-title":"N Engl J Med"},{"key":"2026061712274771200_B9","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.immuni.2020.05.014","article-title":"Determinants of resident tissue macrophage identity and function","volume":"52","author":"Bl\u00e9riot","year":"2020","journal-title":"Immunity"},{"key":"2026061712274771200_B10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","article-title":"Macrophages: versatile players in renal inflammation and fibrosis","volume":"15","author":"Tang","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"2026061712274771200_B11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.kint.2022.10.030","article-title":"Targeting inflammation to treat diabetic kidney disease: the road to 2030","volume":"103","author":"Rayego-Mateos","year":"2023","journal-title":"Kidney Int"},{"key":"2026061712274771200_B12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-pharmtox-051921-085407","article-title":"Lipoxin mimetics and the resolution of inflammation","volume":"63","author":"Godson","year":"2023","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2026061712274771200_B13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41581-021-00454-y","article-title":"Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function","volume":"17","author":"Brennan","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"2026061712274771200_B14","doi-asserted-by":"crossref","first-page":"1072288","DOI":"10.3389\/fendo.2023.1072288","article-title":"The association of cell adhesion molecules and selectins (VCAM-1, ICAM-1, E-selectin, L-selectin, and P-selectin) with microvascular complications in patients with type 2 diabetes: a follow-up study","volume":"14","author":"Siddiqui","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026061712274771200_B15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jdiacomp.2015.02.011","article-title":"Vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1, is associated with diabetic kidney disease in Asians with type 2 diabetes","volume":"29","author":"Liu","year":"2015","journal-title":"J Diabetes Complications"},{"key":"2026061712274771200_B16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/14728222.2023.2187778","article-title":"Targeting VCAM-1: a therapeutic opportunity for vascular damage","volume":"27","author":"Troncoso","year":"2023","journal-title":"Expert Opin Ther Targets"},{"key":"2026061712274771200_B17","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1080\/21655979.2021.1976540","article-title":"Identification and verification of vascular cell adhesion protein 1 as an immune-related hub gene associated with the tubulointerstitial injury in diabetic kidney disease","volume":"12","author":"Jia","year":"2021","journal-title":"Bioengineered"},{"key":"2026061712274771200_B18","doi-asserted-by":"crossref","first-page":"658840","DOI":"10.3389\/fimmu.2021.658840","article-title":"Resolution-based therapies: the potential of lipoxins to treat human diseases","volume":"12","author":"Ja\u00e9n","year":"2021","journal-title":"Front Immunol"},{"key":"2026061712274771200_B19","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2337\/db17-1317","article-title":"Lipoxins protect against inflammation in diabetes-associated atherosclerosis","volume":"67","author":"Brennan","year":"2018","journal-title":"Diabetes"},{"key":"2026061712274771200_B20","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.2017101112","article-title":"Lipoxins regulate the early growth response-1 network and reverse diabetic kidney disease","volume":"29","author":"Brennan","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"2026061712274771200_B21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejmech.2018.10.049","article-title":"Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A4 mimetics (sLXms)","volume":"162","author":"de Gaetano","year":"2019","journal-title":"Eur J Med Chem"},{"key":"2026061712274771200_B22","doi-asserted-by":"crossref","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie Du Sert","year":"2020","journal-title":"PLoS Biol"},{"key":"2026061712274771200_B23","doi-asserted-by":"crossref","first-page":"9193","DOI":"10.1021\/acs.jmedchem.1c00403","article-title":"Asymmetric synthesis and biological screening of quinoxaline-containing synthetic lipoxin A4 mimetics (QNX-sLXms)","volume":"64","author":"de Gaetano","year":"2021","journal-title":"J Med Chem"},{"key":"2026061712274771200_B24","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/sj.ki.5000277","article-title":"Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF","volume":"69","author":"Satchell","year":"2006","journal-title":"Kidney Int"},{"key":"2026061712274771200_B25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/nep.12374","article-title":"Study of microRNA in diabetic nephropathy: isolation, quantification and biological function","volume":"20","author":"Kantharidis","year":"2015","journal-title":"Nephrology (Carlton)"},{"key":"2026061712274771200_B26","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2337\/db08-1666","article-title":"Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail","volume":"58","author":"Brasacchio","year":"2009","journal-title":"Diabetes"},{"key":"2026061712274771200_B27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1681\/ASN.0000000000000345","article-title":"Set7 methyltransferase and phenotypic switch in diabetic glomerular endothelial cells","volume":"35","author":"Maxwell","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"2026061712274771200_B28","first-page":"E83","article-title":"The transcription factor NF-kappa B and the regulation of vascular cell function","volume":"20","author":"De Martin","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026061712274771200_B29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.31083\/j.fbl2809194","article-title":"Epigenetic mechanisms in vascular inflammation: modulation of endothelial adhesion molecules and endothelium-leukocyte adhesion","volume":"28","author":"Calabriso","year":"2023","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2026061712274771200_B30","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00109-021-02066-2","article-title":"Unraveling the epigenetic landscape of glomerular cells in kidney disease","volume":"99","author":"Pereira","year":"2021","journal-title":"J Mol Med (Berl)"},{"key":"2026061712274771200_B31","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1084\/jem.20081188","article-title":"Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia","volume":"205","author":"El-Osta","year":"2008","journal-title":"J Exp Med"},{"key":"2026061712274771200_B32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fcell.2020.00289","article-title":"H3K4me1 distribution predicts transcription state and poising at promoters","volume":"8","author":"Bae","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"2026061712274771200_B33","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1038\/nrdp.2015.18","article-title":"Diabetic kidney disease","volume":"1","author":"Thomas","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2026061712274771200_B34","doi-asserted-by":"crossref","first-page":"158940","DOI":"10.1016\/j.bbalip.2021.158940","article-title":"Lipoxins and synthetic lipoxin mimetics: therapeutic potential in renal diseases","volume":"1866","author":"Andrews","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2026061712274771200_B35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000045084","article-title":"Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients","volume":"79","author":"Bonomini","year":"1998","journal-title":"Nephron"},{"key":"2026061712274771200_B36","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1038\/s41467-023-39740-7","article-title":"An integrated organoid omics map extends modeling potential of kidney disease","volume":"14","author":"Lass\u00e9","year":"2023","journal-title":"Nat Commun"},{"key":"2026061712274771200_B37","doi-asserted-by":"crossref","first-page":"109020","DOI":"10.1016\/j.isci.2024.109020","article-title":"The importance of proinflammatory failed-repair tubular epithelia as a predictor of diabetic kidney disease progression","volume":"27","author":"Tomita-Yagi","year":"2024","journal-title":"iScience"},{"key":"2026061712274771200_B38","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/s41467-024-45706-0","article-title":"Predicting proximal tubule failed repair drivers through regularized regression analysis of single cell multiomic sequencing","volume":"15","author":"Ledru","year":"2024","journal-title":"Nat Commun"},{"key":"2026061712274771200_B39","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/ijms19041057","article-title":"Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer","volume":"19","author":"Kong","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2026061712274771200_B40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41569-022-00770-1","article-title":"Vascular endothelial cell development and diversity","volume":"20","author":"Trimm","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"2026061712274771200_B41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41581-021-00411-9","article-title":"Phenotypic diversity and metabolic specialization of renal endothelial cells","volume":"17","author":"Dumas","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"2026061712274771200_B42","doi-asserted-by":"crossref","first-page":"F465","DOI":"10.1152\/ajprenal.00036.2023","article-title":"The unique structural and functional characteristics of glomerular endothelial cell fenestrations and their potential as a therapeutic target in kidney disease","volume":"325","author":"Finch","year":"2023","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026061712274771200_B43","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1186\/1471-2164-15-725","article-title":"A SAGE based approach to human glomerular endothelium: defining the transcriptome, finding a novel molecule and highlighting endothelial diversity","volume":"15","author":"Sengoelge","year":"2014","journal-title":"BMC Genomics"},{"key":"2026061712274771200_B44","doi-asserted-by":"crossref","first-page":"573557","DOI":"10.3389\/fphar.2020.573557","article-title":"Glomerular endothelial cells as instigators of glomerular sclerotic diseases","volume":"11","author":"Sol","year":"2020","journal-title":"Front Pharmacol"},{"key":"2026061712274771200_B45","doi-asserted-by":"crossref","first-page":"655639","DOI":"10.3389\/fmed.2021.655639","article-title":"Glomerular endothelial cells are the coordinator in the development of diabetic nephropathy","volume":"8","author":"Li","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2026061712274771200_B46","doi-asserted-by":"crossref","first-page":"F716","DOI":"10.1152\/ajprenal.00314.2016","article-title":"Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets","volume":"312","author":"Pichler","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026061712274771200_B47","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1046\/j.1464-5491.2000.00347.x","article-title":"Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy","volume":"17","author":"Clausen","year":"2000","journal-title":"Diabet Med"},{"key":"2026061712274771200_B48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1590\/2359-3997000000116","article-title":"Evaluation of biochemical and clinical markers of endothelial dysfunction and their correlation with urinary albumin excretion in patients with type 1 diabetes mellitus","volume":"60","author":"Polat","year":"2016","journal-title":"Arch Endocrinol Metab"},{"key":"2026061712274771200_B49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10875-007-9137-4","article-title":"Aberrant expression of soluble co-stimulatory molecules and adhesion molecules in type 2 diabetic patients with nephropathy","volume":"28","author":"Wong","year":"2008","journal-title":"J Clin Immunol"},{"key":"2026061712274771200_B50","first-page":"CR349","article-title":"Correlation between circulating adhesion molecule levels and albuminuria in type 2 diabetic normotensive patients","volume":"13","author":"Rubio-Guerra","year":"2007","journal-title":"Med Sci Monit"},{"key":"2026061712274771200_B51","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000210554","article-title":"Correlation between circulating adhesion molecule levels and albuminuria in type-2 diabetic hypertensive patients","volume":"32","author":"Rubio-Guerra","year":"2009","journal-title":"Kidney Blood Press Res"},{"key":"2026061712274771200_B52","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1159\/000493619","article-title":"Transient high-glucose stimulation induces persistent inflammatory factor secretion from rat glomerular mesangial cells via an epigenetic mechanism","volume":"49","author":"Yunlei","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"2026061712274771200_B53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"2026061712274771200_B54","doi-asserted-by":"crossref","first-page":"e02177","DOI":"10.1128\/JVI.02177-19","article-title":"Concurrent control of the Kaposi\u2019s sarcoma-associated herpesvirus life cycle through chromatin modulation and host hedgehog signaling: a new prospect for the therapeutic potential of lipoxin A4","volume":"94","author":"Asha","year":"2020","journal-title":"J Virol"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/4\/710\/857335\/db250970.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/4\/710\/857335\/db250970.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:28:01Z","timestamp":1781713681000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/75\/4\/710\/164503\/Epigenetic-Regulation-of-VCAM-1-by-Lipoxin-A4-Is"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":54,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2,18]]},"published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db25-0970","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]}}}